SSY GROUP (02005) obtained the drug production registration certificate for sodium glycerophosphate injection (10ml:2.16g).

08:20 29/12/2025

ShiSi Pharmaceutical Group (02005) announced that the group has obtained the drug production registration certificate for sodium glycerophosphate injection (10ml:2.16g) from the China National Medical Products Administration. This drug belongs to the category 4 of chemical drugs, and is considered to have passed consistency evaluation. It is the third domestic enterprise to receive approval. Sodium glycerophosphate injection is a nutritional medicine mainly used as a phosphorus supplement for adult parenteral nutrition and for patients with phosphorus deficiency.

SSY GROUP (02005) announced that the group has obtained the drug production registration approval from the China National Medical Products Administration for the sodium glycerophosphate injection (10ml: 2.16g), which belongs to Class 4 chemical drugs. It is considered equivalent to passing consistency evaluation, and is the third domestic enterprise to receive approval. Sodium glycerophosphate injection is a nutritional drug mainly used as a phosphorus supplement for adult parenteral nutrition and for patients with phosphorus deficiency.

HK Stock Market Move | ND PAPER(02689) rose more than 6% with the industry showing a double trend of "shutdown + price increase". The improvement of inventory cycle is expected to strengthen the expectation of economic recovery.

HK Stock Market Move | Goldwind Science & Technology (02208) rose over 13% in early trading. The process of the commercial rocket company's IPO may be accelerated. The company holds a 8.3% stake in Blue Sword Aerospace.

HK Stock Market Move | DOBOT(02432) rose more than 6%, and the company's two shareholders have voluntarily promised not to reduce their holdings for one year.